Type 1 Diabetes Flashcards
Cause/Clinical Onset/Prevalence
AUTOIMMUNE DESTRUCTION OF PANCREATIC BETA ISLET CELLS
Clinical onset at 80% beta cells lost
Genetic and Environmental etiology
Prev: 1/300 gen pop, 1/20 if first degree rel, 1/1-3 in monozygotic twin
Higher in western Europe, US, Australia, Lower in Africa and Chine
Genetics
Risk/Protective/Insulin gene
Risk is ADDITIVE!
Risk: HLA-DR3/4 (codes MHC class II)
Protective: HLA-DR2
Insulin gene: Class I VNTR (tandem repeats) in 5’ region –> less insulin expressed in thymus –> decreased ability to distinguish insulin as pathogen rather than self
Environmental
Viruses, breastfeeding, timing of food introduction
Hygiene hypothesis, accelerator hypothesis (obesity speeds up onset)
Vit D may be protective
Associated co-morbidities
Automimmune thyroid (15-20%)
Celiac (5-10%)
Addison’s (1-1.5%)
DIAGNOSTIC: Fasting glucose/OGTT/random blood sugar
> 126 mg/dl on 2 occasions (FASTING so no food for >8hrs)
OGTT (2 hr oral glucose tolerance test): >200 mg/dl
Random blood sugar >200 AND sx of DM
DIAGNOSTIC HbA1c/Ab/labs (4 things)
HbA1c >6.5% on 2 occasions
Islet cell Ab (ICA) to islet autoantigens (IA-2, GAD65, ZnT8) or insulin itself (mIAA)
If you have 2+ ICAs then will progress to DM
Most of the damage is T-cell mediated (although there are Ab, no good test for T-cell)
LOW C-PEPTIDE
Decreased First phase insulin response (FPIR = insulin released in 1st and 3rd minute following IV glucose)
Treatment
humanized INSULIN (shots or continuous SC infusion)
STATINS (only >40 yrs if lipid profile normal)
CONTINUOUS GLUCOSE MONITORING SYSTEMS
Primary Prevention
infant diet changes etc. to STOP BEFORE DEVELOPMENT OF autoAb
Secondary Prevention
prevent the autoAb from developing clinical sx (ie. oral insulin)
Tertiary Insulin
prevent progression of dz (ie with anti-CD3 Ab, Abatacept)
DAISY study findings
Diabetes Autoimmune Study in the Young
AutoAb negative until ~8yrs
Clinical signs of M at 11-15 yrs
If have 2+ positive ICA then they’ll get diabetes (just matter of time)
Presentation (age/sx/acute pres/family hx/)
Usually in childhood (peak incidence is 10-12 yrs old, though presenting more in